palbociclib,ribociclib
novartis,pfizer
['bcsm', 'palbo', ' ribo', 'palbociclib', 'ribociclib']
in the metastatic setting, what do we use post cdk 4/6 therapy? maintain tells us that there is benefit in ribociclib post palbociclib and pace tells us no benefit in palbo post palbo but these are both smaller phase 2 trials. #bcsm #asco23
Breast & gyn med onc @valleyhealthnj. Opinions my own. RT not endorsements. Host of INTERLUDE podcast 🎤 ASCO FCOI= https://t.co/C54erlhQe8